GenScript Receives Emergency Use Authorization from the FDA for Use of SARS-CoV-2 cPass (TM) Neutralizing Antibodies in Convalescent Plasma Screening
COVID-19 vaccines, the tests work well now, but the variants have the FDA preparing for a future in which it may not